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ABSTRACT
Background: With advances in management, education, awareness and improved nutrition, men and 
women with sickle cell disease are enjoying an improved quality of life well into adulthood, when they elect 
to plan a family. As a result, sickle cell disease is a common haemoglobinopathy encountered during 
pregnancy in Nigeria. Reports from other parts of the country have documented increased maternal and 
perinatal morbidity and mortality, but none has been reported from Jos.
Materials and Methods: A retrospective review of pregnancy outcome in patients with sicle cell disease 
managed at the Jos University Teaching Hospital, Jos over a 5year period was carried out. Data extracted 
from patients' case files were analysed using simple statistical methods with Epi info 2002 statistical 
software.
Results: Case files of patients with sickle cell disease in pregnancy during the period under review were 
retrieved. The mean maternal age was 25.1±3.9 years. The mean gestational age at booking or first 
presentation was 19.3±7.7 weeks. The antenatal complications included anaemia (62.9%), vaso-oclusive 
(bone pain) crisis (58.1%), intra uterine growth restriction (45.7%), pregnancy induced hypertension and 
malaria 25.7% each. The maternal and perinatal mortality rates were 53 and 384 per 1000 live births 
respectively.
Conclusion: Pregnancy in sickle cell disease patients is associated with high maternal and perinatal 
morbidity and mortality as reported in other parts of the country. The importance of early presentation for 
antenatal care and a call for preconception care is made.
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INTRODUCTION:
The term sickle cell disease refers to a lifelong 
disorder arising from the inheritance of two 
abnormal haemoglobin genes, each from a parent 
with at least one of the two abnormal genes being 
haemoglobin S.  Examples of sickle cell disease are 
HbSS, HbSC and HbSB-thalasaemia. 
In the deoxygenated state the HbS molecule forms 
polymers which lead to sickling of the red blood 
cells. The heterozygous form of sickle cell 
haemoglobinopathy (HbAS) is essentially a benign 
condition that is believed to have no particular 
antenatal sequelae.  It confers partial protection 
1-3from falciparum malaria.  The prevalence of 
sickle cell diseases is highest in Africans and people 
2,4,5of Mediterranean or East Indian ancestry.
With advances in management, education, 
awareness and improved nutrition, men and women 
with sickle cell disease are enjoying an improved 
quality of life well into adulthood, when they may 
elect to plan a family, as a result, sickle cell disease 
is a common haemoglobinopathy encountered 
during pregnancy in Nigeria.
There are, however, increased risks involved in 
pregnancy for the mother with sickle cell disease 
and her foetus.  Maternal risks include exacerbated 
sickle cell disease phenomena such as anaemia, 
vaso-oclusion, and ischaemic injury as a result of 
3the physiologic stress of pregnancy.  They have 
greater susceptibility to chest and urinary tract 
infections, hypertensive disorders of pregnancy and 
2,5-7
thrombo embolic complications. Risks to the 
foetus include increased frequency of miscarriage, 
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intra uterine growth restriction and preterm labour 
and premature delivery.  Perinatal morbidity and 
mortality are higher than in the general 
2-6population. Despite risks associated with sickle 
cell disease in pregnancy, appropriate management 
by health care providers familiar with sickle cell 
diseases and high risk obstetric care can result in 
successful pregnancy outcomes in patients with 
3,5,6,8.sickle cell diseases  The pregnant woman 
suffering from sickle cell disease must be regarded 
as high risk.
Studies in Ibadan, Lagos, Enugu and other parts of 
southern Nigeria have all documented increased 
maternal  and per inata l  morbidi ty  and 
10,11,14
mortality,  but there has been paucity of reports 
of pregnancy outcome in sickle cell disease from 
northern Nigeria.  The objective of this study was 
to review the pregnancy outcomes in patients with 
sickle cell disease as seen at the Jos University 
Teaching Hospital, North Central Nigeria.
MATERIALS AND METHODS
This was a retrospective study of women with 
sickle cell disease who presented with pregnancy at 
the Jos University Teaching Hospital (JUTH) 
st
between 1st January 2003 and 31  December 2007. 
A thorough search of the antenatal, labour and 
delivery records of the obstetric unit as well as the 
records of the medical records department of the 
hospital was done to identify these patients. Their 
case files were retrieved from the Medical Records 
Department and studied.  
Data extracted from the patients case files 
included:  Age, parity, gestational age at booking, 
complications of the disease and pregnancy during 
the antenatal period, labour and puerperium.  
Information about mode of delivery and foetal 
outcome were also extracted from the case files. 
The data obtained was then analysed using simple 
statistical methods with Epi info 2002 statistical 
soft ware.
RESULTS
During the period under review, there were 13611 
deliveries,and forty four women had sickle cell 
disease in pregnancy. Only the case files of 
38patients with sickle cell disease in pregnancy 
could be retrieved.  Thirty seven pregnancies were 
complicated by HbSS while one pregnancy was 
complicated by HbSC.
The mean maternal age was 25.05 ± 3.87 years.  
About 58% of the patients had secondary school 
education while 21% each had primary and tertiary 
education respectively.Over half (57.9%) of the 
patients were nullipara while none of the women 
had parity greater than three.
The mean gestational age at booking or first 
presentation was 19.3 +/- 7.7 weeks with only 
25.7%( 9) of the patients booking or presenting 
before 13weeks of gestation. Three women were 
referred in labour, having had there antenatal care 
elsewhere. The mean packed cell volume at booking 
was 26.3± 5.2%. About 68.9% of the patients 
required antenatal admission during the pregnancy 
due to maternal or foetal complications, with about 
41.7% of these, requiring more than one antenatal 
admission during the pregnancy. 
About sixty three (62.9%) percent of the patients 
had anaemia, with 31.4% presenting with severe 
anaemia (PCV ≤ 18%) or anaemic heart failure 
during the antenatal period. Bone pain crisis 
(51.4%), pregnancy induced hypertension (25.7%) 
and malaria (25.7%) were other common 
antepartum maternal complications observed.  One 
patient with twin pregnancy had eclampsia at 32 
weeks of gestation.
 Intrauterine growth restriction was observed in 
45.7% of the pregnancies while intrauterine foetal 
death occurred 20.5% of the patients, (Table 1). 
About forty two percent of the patients required 
antenatal blood transfusion; the mean number of 
units transfused was 3.3 pints (range 1-5).
The mean gestational age at delivery was 36.9 ± 
2.29 weeks (range 32 – 41 weeks), with about 
42.9% of the patients delivering before 37 
completed weeks of gestation.  The mean packed 
cell volume in labour was 24.07 ± 5.74 %, (range 
15-34%). About seventy four percent (73.7%) of the 
pregnancies were delivered vaginally while 26.3% 
had caesarean section. The instrumental delivery 
rate was 26.3%, six women had vacuum and four 
had forceps delivery.The most common intrapartum 
complication observed in this series was anaemia 
(58.1%), other complications noted were: vaso 
occlusive crisis, foetal distress and failure to 
progress in labour due to cephalo pelvic 
disproportion (Table 2). 
The mean birth weight was 2.39 ± 0.5kg, (range 1.3-
3.2kg) with 69.2% of the babies weighing less than 
2.5kg. The mean Apgar score at 5 minutes was 7.02 
± 2.24, (n=30). There were 15 perinatal deaths 
(38.4%). This was made of 8 (20.5%) stillbirth and 7 
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(17.9%) early neonatal deaths.
The commonest puerperal complication was 
anaemia (57.9%) with 36.8% requiring blood 
transfusion in the postpartum period. Other 
puerperal complications included bone pain crisis 
(10.5%), post caesarean section wound infection 
(5.3%). One patient had puerperal psychosis 
following a macerated stillbirth.About 28.9% of 
the patients had no puerperal complications, (Table 









         




































There were two maternal deaths (5.3%), both 
occurring within seven days of delivery. The two 
maternal deaths had anaemia as a complication of 
their pregnancies, with one referred from a primary 
health care clinic in labour with anaemic heart 
failure.  
Table 2: *Intrapartum complications in sickle cell disease patients 
 Complication †N=31 % 



































Table 3: *Puerperal complications of patients with sickle cell disease in Pregnancy 
 
Complication  Freq (N=38) % 




































This review indicates that pregnancy in sickle cell 
disease patients is still associated with high 
maternal morbidity and mortality and poor 
perinatal outcome in Jos, North Central Nigeria.  
This may be partly related to the finding in this 
review which  shows that a high proportion of the 
women booked for antenatal care in the second 
trimester, indicating that these patients may not 
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have realized that there pregnancy was associated 
with higher risk than their counterparts with normal 
haemoglobin. This is despite the fact that most of 
them (79%) had more than primary education. This 
relatively late booking may have accounted for the 
high incidence of antenatal admissions in this 
study. It is also worthy to note that one of the 
patients that died had her antenatal care at a 
primary health care centre and was only referred in 
labour.This calls for a need to intensify health 
education for these patients. Our community health 
workers also need some education on the risk 
associated with pregnancy in sickle cell disease 
patients.
The high incidence of anaemia (62.9%) observed 
in this study was similar to the finding of a similar 
15
study in Ibadan, south western Nigeria . Another 
similar study in Abraka Delta state Nigeria 
however observe a higher incidence of 92.25% 
11
.This study however observed a higher incidence 
of severe anaemia  compared to that observed in 
15
Ibadan  and consequently, a high frequency of 
antenatal blood transfusions. This has serious 
implication for the risk of transmission of HIV and 
other related infections in these patients.
The chronic haemolytic state of sickle cell disease 
patients associated with increased requirement for 
haemopoeitic nutrients in pregnancy increased 
their susceptibility to anaemia. Prophylactic blood 
transfusion was suggested in the past as a way of 
16
improving the maternal and perinatal outcome;  
however, randomized studies have not shown any 
17
benefit over selective blood transfusion,  hence the 
practice in our hospital has been to transfuse these 
patients only when clinically indicated. 
This study however observed a higher incidence of 
bone pain crisis (51.4%) compared to those in 
 11  Abraka, Delta state (23.81%)  and Ibadan (7.3%)
15
. This may reflect a true higher incidence of bone 
pain crisis in this part of the country compared to 
those of Ibadan and Abraka. However,studies in the 
United States and nearby Cotonou, Benin republic 
recorded similar incidences of 50% and 57% 
12,13respectively of bone pain crisis in larger series .
Malaria in pregnancy was also a common 
complication in pregnancy in this series occurring 
in 25.7% of pregnancies. This was similar to the 
14.incidence (22.4%) observed in Lagos  The 
incidence of pregnancy induced hypertension of 
25.7% observed in this study was higher than that 
15
observed in Ibadan . The high proportion of 
nullipara in this study may be responsible for this. 
Other studies from Atlanta (USA), Jamaica and 
Baharain showed no significant difference in risk of 
pregnancy induced hypertension or preeclampsia 
between patients with sickle cell disease and those 
9, 18, 19
with normal haemoglobin genotypes . These 
discrepancy calls for further research in this area.
Other maternal complications observed included 
urinary and respiratory tract infections, and 
pseudotoxaemia, which is consistent with 
10-12  14, 15
complications recorded in other studies , .
There was also a high caesarean section and 
instrumental delivery rates compared to the 
institution rates of 17% and 1.4% respectively. 
Other studies also observed higher caesarean 
section and instrumental delivery in patients with 
11,15,19
sickle cell disease in pregnancy . This could be 
due to the high incidence of maternal and fetal 
complications often leading to delivery by 
caesarean section. Most Obstetricians in our centre 
routinely shorten the second stage of labour in these 
patients, this therefore explain the high instrumental 
delivery rate.
Babies of sickle cell disease patients were also 
noted to have lower gestational age at delivery and 
lower birth weights. This is in contrast with the 
study in Ibadan which observed no difference in 
gestational age at delivery with patients with normal 
15
haemoglobin . It is, however, comparable with 
findings from studies from Jamaica and in the 
United States which also observed lower birth 
13,18weights and gestational age at delivery.   Factors 
responsible for lower birth weight for mothers with 
sickle cell disease are varied and inconsistent, but 
18
have included lower gestational age , lower 
maternal weight, history of pre-eclampsia, acute 
anaemic episodes and the number of sickle cell 
10related complications during pregnancy . Lower 
gestational age could be influenced by a high 
frequency of early surgical delivery or premature 
induction both of which are common interventions 
in management of pregnancy among mothers with 
sickle cell disease, though this was not the case in 
this review..
The high perinatal and maternal mortality observed 
in this study are in agreement with findings of 
9-11 similar studies within and outside the country 
14,15,18-23
.
Though our study is limited by its retrospective 
nature with only thirty eight of the forty four case 
files retrieved, the findings are still pertinent.There 
is need for pre conception care for these patients and 
closer monitoring during antenatal care, labour and 
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pueperium by a multidisciplinary team of 
obstetricians, haematologist and trained sickle 
nurses.
The importance of early presentation for prenatal 
care should be stressed to these patients so that 
antenatal complications can be detected and treated 
early.
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